- Presentations
- 2
- Markets
- 1
Zoladex is a brand of Goserelin marketed by TerSera Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Goserelin
- Brand owner
- TerSera Therapeutics
- Registered in
- United States
- Strengths and forms
- 10.8 mg implant, 3.6 mg implant
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Zoladex 10.8 mg implantSubcutaneous | TerSera Therapeutics | US FDA | Available on request |
| Zoladex 3.6 mg implantSubcutaneous | TerSera Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Zoladex
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.